C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2002
12/05/2002	US20020182652 Detection of preferential protein in sample; obtain sample of protein mixture, incubate with probe, detect signal from probes
12/05/2002	US20020182643 Detecting preferential ligands in cell; obtain cell, incubate with reporter molecules, detect reporter in cell
12/05/2002	US20020182635 Methods of screening for LTRPC2 modulators
12/05/2002	US20020182634 Detection of varicella-zoster virus
12/05/2002	US20020182628 Nucleotide sequences probes for use in the detection chromosomal gene rearrangments
12/05/2002	US20020182627 Biochips including ion transport detecting strucutres and methods of use
12/05/2002	US20020182626 Episomal non-transforming nucleic acid elements in functional genomic and antigenic applications
12/05/2002	US20020182624 Chemokine receptors and disease
12/05/2002	US20020182623 Reagent and process for the identification and counting of biological cells
12/05/2002	US20020182622 Method for SNP (single nucleotide polymorphism) typing
12/05/2002	US20020182621 Methods and compositions using cap43 proteins and nucleic acids to diagnose and treat cancer and other disorders
12/05/2002	US20020182620 Quantitative determination of nucleic acid amplification products
12/05/2002	US20020182619 Compositions, kits, and methods for identification, assessment, prevention, and therapy of ovarian cancer
12/05/2002	US20020182618 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/05/2002	US20020182617 Binding assay using binding agents with tail groups
12/05/2002	US20020182616 Diagnosis of eating disorders in humans; obtain sample, incubate with probes, detect hybridization signal, presence of signal indicates polymorphism and sensitivity to eating disorder
12/05/2002	US20020182615 All in one nucleic acid amplification assay
12/05/2002	US20020182614 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
12/05/2002	US20020182613 Nanoparticles having oligonucleotides attached thereto and uses therefor
12/05/2002	US20020182612 Diagnosing inflammatory defects in humans; obtain nucleotide sequence sample, incubate with probe associated with preferential allele, detect hybridization, hybridization indicates sensitivty to inflammatory defect
12/05/2002	US20020182611 Detecting preferential nucleotide sequences in sample; obtain oligonucleotides, incubate with nucleotide sequence sample, detect hybridization
12/05/2002	US20020182609 Microsphere based oligonucleotide ligation assays, kits, and methods of use, including high-throughput genotyping
12/05/2002	US20020182608 Providing a device for detecting presence of target nucleic acid molecule; contacting probes with sample which may have target nucleic acid molecule under selective hybridization conditions, determining if electrical current can be carried
12/05/2002	US20020182607 Compositions and methods for parsing gene structure
12/05/2002	US20020182606 Detection of single nucleotide polymorphisms
12/05/2002	US20020182605 Determining which of angiotensin receptor 1 (AGTR1) gene halotypes defines one copy of individual's AGTR1 gene wherein each of the AGTR1 haplotypes comprises a set of polymorphisms
12/05/2002	US20020182602 Biopolymer for use in the detection of preerential sequences in sample
12/05/2002	US20020182601 Method and reagents for analyzing the nucleotide sequence of nucleic acids
12/05/2002	US20020182600 Detecting preferential particles in sample; obtain mixture of synthetic nucleotide sequences, conjugate to indicator, detect preferential sequences
12/05/2002	US20020182598 Digesting a DNA sample with a restriction endonuclease; ligating a double stranded Amp- probe to each end of the fragmented DNA; separating excess unligated Amp-probe; denaturing the DNA fragments; amplification
12/05/2002	US20020182597 Used for screening for protein-compound interactions such as protein- therapeutic compound interactions
12/05/2002	US20020182596 Compounds for immunodiagnosis of prostate cancer and methods for their use
12/05/2002	US20020182595 Detection of proteins that bind to regulatory sequences; obtain nucleotide sequences, incubate with protein, detect bound nucleotide sequences
12/05/2002	US20020182594 Chemomagnetic retrieval of CMV and CMV infected cells
12/05/2002	US20020182592 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
12/05/2002	US20020182590 Monitoring polypeptide activation; obtain nucleotide sequences, incubate with cells, monitor phenotypic expression, associate phenotypic expression with protein
12/05/2002	US20020182588 Induction of apoptosis by cellular stress
12/05/2002	US20020182585 Therapeutic treatment for vascular defects
12/05/2002	US20020182581 Treating blood or blood products with compounds which have a mustard, aziridinium or aziridine group and a nucleic acid binding group
12/05/2002	US20020182215 Especially the amino acid sequence Ile-Phe-Ala-Gly-Asp-Lys-Phe-Trp-Arg, preferably flanked by cysteine residues at the amino and carboxy termini.
12/05/2002	US20020182207 Contacting said target molecule with a catalyst capable of chemically modifying said target molecule; catalyzing the attachment of the label to the target substance
12/05/2002	US20020182197 System for screening fatty acid transport inhibitors, methods of use and modulators identified thereby
12/05/2002	US20020182188 Making by debulking a suspension of human liver tissue under conditions to remove mature cells, while retaining immature cells having markers for the expression of alpha-fetoprotein, and/or albumin
12/05/2002	US20020182153 Method for detecting chitin-containing organisms
12/05/2002	US20020182117 Determination target compounds; immobilization
12/05/2002	US20020182109 Gene sequence-reading instrument
12/05/2002	US20020180572 Electromagnetic device and high-voltage generating device and method of producing electromagnetic device
12/05/2002	US20020179442 Sample solution containing sugar alcohol
12/05/2002	US20020179441 Biosensor and method of producing the same
12/05/2002	US20020179097 Method for providing clinical diagnostic services
12/05/2002	DE19941359C2 Schneller, hochspezifischer Nachweis von Pseudomonas aeruginosa durch Mehrfachsondendetektion Fast, highly specific detection of Pseudomonas aeruginosa by multiple probe detection
12/05/2002	DE19934573C2 Verfahren zur Markierung von festen, flüssigen und gasförmigen Substanzen A method for marking solid, liquid and gaseous substances
12/05/2002	DE10127572A1 Werkzeuge zur Diagnostik, molekularen Definition und Therapieentwicklung chronischer entzündlicher Gelenkerkrankungen Tools for diagnostics, molecular definition and therapy development of chronic inflammatory joint diseases
12/05/2002	DE10126472A1 Verwendung des Nachweises der Expression von Splice-Varianten von Gen21 für die Diagnose und Therapie von Tumorerkrankungen Using the detection of the expression of splice variants of Gen21 for the diagnosis and therapy of tumor diseases
12/05/2002	DE10126083A1 Verwendung von optischen Diffraktionselementen in Nachweisverfahren Use of optical diffractive elements in detection methods
12/05/2002	DE10125538A1 Detecting low molecular weight substances in aqueous solution, useful for determining e.g. pharmaceuticals, involves competitive reaction and nucleic acid amplification
12/05/2002	DE10125018A1 Detecting molecules in liquid, e.g. DNA analysis, involves fixing receptor molecules to substrate and determining flow characteristics of reference liquid and liquid for analysis
12/05/2002	DE10124872A1 Fabrication of microdevices for separation of biomolecules in an electric field involves a vapor deposition coating process with the coating including functional groups having an intrinsic reactivity to react with target molecules
12/05/2002	DE10124820A1 Zusammensetzung und Verwendung von Substanzen zur Stabilisierung von schwefelhaltigen Aminosäuren im Blut Composition and use of substances for the stabilization of sulfur-containing amino acids in blood
12/05/2002	DE10124792A1 Verfahren zum Nachweis und zur Differenzierung von pflanzenpathogenen Subspezies der Art Clavibacter michiganensis Michiganensis method for the detection and differentiation of plant pathogenic subspecies of the species Clavibacter
12/05/2002	DE10122659A1 Biochip-Anordnung Biochip arrangement
12/05/2002	DE10103954A1 Verfahren zur Analyse von Makromolekülen A process for the analysis of macromolecules
12/05/2002	CA2616769A1 Compositions and methods of increasing stress tolerance in plants
12/05/2002	CA2487821A1 Method to identify constituent proteins by peptides profiling
12/05/2002	CA2449245A1 Small molecule antagonists of bcl2 family proteins
12/05/2002	CA2449190A1 Use of optical diffraction elements in detection methods
12/05/2002	CA2449017A1 Neuroblastoma cell lines expressing the alpha2delta subunit of calcium channels and methods therefore
12/05/2002	CA2449004A1 Melanin-concentrating hormone analogs
12/05/2002	CA2448953A1 Assay for beta cell toxic macrolides
12/05/2002	CA2448757A1 Accurate and efficient quantification of dna sensitivity by real-time pcr
12/05/2002	CA2448711A1 Use of duckweed in high throughput screening
12/05/2002	CA2448569A1 Compositions and methods for the inference of pigmentation traits
12/05/2002	CA2448567A1 Modulators of nucleic acid ligands
12/05/2002	CA2448484A1 Diagnostic methods for cardiovascular disease, low hdl-cholesterol levels, and high triglyceride levels
12/05/2002	CA2448362A1 B7 related protein-2 molecules and uses thereof
12/05/2002	CA2448148A1 Carbohydrate-associated proteins
12/05/2002	CA2448146A1 Secreted proteins
12/05/2002	CA2448116A1 Molecules for disease detection and treatment
12/05/2002	CA2448109A1 Alternative splice forms of proteins as basis for multiple therapeutic modalities
12/05/2002	CA2448096A1 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
12/05/2002	CA2447916A1 Tumor endothelial marker 7.alpha. molecules and uses thereof
12/05/2002	CA2447879A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	CA2447691A1 Secretion of proteins by encapsulated cells
12/05/2002	CA2447662A1 Transporters and ion channels
12/05/2002	CA2447463A1 A quantitative hybridization assay for the analysis of nucleic acid
12/05/2002	CA2447226A1 Method for producing a layer of functional molecules
12/05/2002	CA2445611A1 P-cadherin as a target for anti-cancer therapy
12/05/2002	CA2443713A1 Proteins associated with cell growth, differentiation, and death
12/05/2002	CA2441937A1 Chromosome-based platforms
12/04/2002	EP1262769A1 Improved electrochemical sensor
12/04/2002	EP1262768A1 Analytical element, and measuring instrument and substrate determining method using the same
12/04/2002	EP1262565A2 Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases
12/04/2002	EP1262564A2 Dna sequencing by mass spectrometry
12/04/2002	EP1262563A2 Method for immobilizing DNA on a surface
12/04/2002	EP1262562A2 Actinomycetes polynucleotides
12/04/2002	EP1262561A1 Method for the detection and identification of Clavibacter michiganensis
12/04/2002	EP1262560A2 Method of forming cDNA from an RNA target sequence present in a sample
12/04/2002	EP1262559A1 Dermal patch for detecting lactate
12/04/2002	EP1262556A2 Antimicrobial peptides and method for identifying and using such peptides
12/04/2002	EP1262553A1 Luciferase-selection marker fusion proteins, polynucleotides encoding such proteins, and uses thereof

1 ... 2202 2203 2204 2205 2206 2207 2208 2209 2210 2211 2212 2213 2214 2215 2216 2217 2218 2219 2220 2221 2222 ... 3003